Summary
Overview
Work History
Education
Skills
Certification
Publications/presentations
Selectedpublications
Languages
Reference
Timeline
Generic

Lauren Lian

Haddonfield,NJ

Summary

Cellular and immunological scientist specializing in CAR-T and CAR-Macrophage immunotherapy for various cancer cells. Demonstrated expertise in conducting in vitro and in vivo experiments, including hands-on proficiency in generating and evaluating tumor cell and CAR-T/CAR-M cell cultures. Experienced in creating tumor mice models and assessing the effectiveness of CAR-T/CAR-M cells in killing tumor cells across multiple settings. Skilled in data analysis and flow profiling of CAR-T or CAR-M cells using Microsoft Office, GraphPad, Flowjo, ImageJ, Halo, and Live image.

Overview

22
22
years of professional experience
1
1
Certification

Work History

SENIOR ASSOCIATE

SCIENTIST Carisma Therapeutic, Inc, Discovery
06.2022 - 12.2024

Projects:

Evaluation of CAR-Macrophage killing tumor cell in vitro _ In vitro team


Duties:

  • Lentivirus titration, Murin BMP, Murine Myeloid cell isolation/expansion, Human Monocyte isolation
  • Macrophage induction, Verification, Lentivirus transduction, CAR-Macrophage generation, and evaluation of CAR-Macrophage killing tumor cell in vitro, Murine T cells isolation, and verification


Projects:

Evaluation of efficacy of CAR-Macrophage to various Human or Murine tumor cells implanted mice models in vivo and ex vivo _ In vivo team


Duties:

  • Human/Murine GPC3 cell line generation in vitro, or ex vivo, purification, verification, expansion, cryopreservation, validation in vitro and in vivo
  • Human/Murine c-MET tumor cell line generation in vitro, or ex vivo, purification, verification, expansion, cryopreservation, validation in vitro and in vivo
  • Human/Murine GPC3 or c-MET stable cell line generation and validation in vitro and in vivo
  • Evaluation of multiple Human/Murine GPC3 or c-MET tumor cells growth kinetics in vivo with both xenograft and syngeneic mice models in various mice strains
  • Evaluating the efficacy of CAR binders of GPC3 or c-MET to various Human or Murine tumor cells in vivo
  • Duties:
  • Various human and murine tumor cell line generation, selection, verification, expansion, cryopreservation, validation in vitro, in vivo and ex vivo
  • Xenograft and Syngeneic mice models development/generation, observation, monitoring by measuring mice healthy conditions and body weight, subcutaneous tumor burden measurement, live bioluminescent imaging, treatment, takedown mice and various tissues harvest and procession, ex vivo tumor cell validation
  • Tissue preparation for FFPE blocker, manage outsourcing services for tissue FFPE blocker preparation and IHC staining
  • In vitro, in vivo and ex vivo data collection, IHC image analysis with Halo, 3DHISTEC-SlideViewer for IHC image analysis, data analysis with GraphPad Prism software, summarization and presentation
  • Cryovials generation and management (banking and recording in Benchling)
  • Contribute in vivo procedure protocol generation and review for GPC3 project IND application as well as research lab safety inspections
  • Collaborating with other teams for taking down mice and tissue harvesting/processing
  • Collaborating with in vitro teams for LNP handling, registration in Benchling, and banking
  • Author and review technical documents for preparing IND submission.

RESEARCH SPECIALIST

D MED, University of Pennsylvania, Pulmonary, Alle
11.2017 - 06.2022

Projects:

  • The role of Tim3 and CEACAM1 in anti-tumor function of human affector T cells
  • Extending chimeric antigen (CAR) T cell therapy to thoracic cancers
  • Predictors of anti-PD1 response and relapse in front line lung cancer patients using fine needle aspirates- FNA-Merck clinical research project
  • Penn-Incyte adenosine project alliance - Role of Inflammasome in Human Lung Cancer
  • Kitov Pharma project - Evaluate anti-Ceacam1 antibody in CAR T cell killing to tumor cells in vitro
  • Duties:
  • Designing research method and generating or modifying experiment protocols based on the hypothesis and aim for each of research projects
  • Executing experiments for generating the different CAR T cells in large scale and the targeted tumor cell lines by retrovirus and lentivirus transduction
  • Performing CAR T cell killing assays in vitro, and ex vivo with or without the inhibition of bispecific blocking antibodies, and in vivo experiments of CAR T cell cancer immunotherapy in solid tumor NSG mice models by subcutaneously injected lung cancer cells with or without CAR T cell treatment via tail vein injection and harvesting/phenotyping tumor infiltrated T cells (TILs) from tumor nodules
  • Discovering the potential mechanism by performing immunocytochemical staining for live imaging for killing, flow cytometer, immunofluorescence confocal image, scanning electron microscope (SEM) image in activated CAR T cell post interaction with tumor cells in vitro, and immunohistochemistologic assay for phenotyping TILs in the tumor nodules harvested from tumor mice models
  • Handling multiple research projects under the guidance of Principal Investigator by establishing experimental plan, executing experiments, analyzing and summarizing data for research projects progress report
  • Responsible for managing teamwork to performing large scale experiments and accomplishing assay data analysis and report
  • Taking responsibility for collaborating tasks, coordinating with clinical research team on time and performing, producing patient oriented clinical research experiments and data report accordingly
  • Engaging in data progress report and manuscript preparation as well as updating project progress report
  • Managing all research lab related tasks including lab safety, ordering and managing lab supplies (e.g stocks’ in both physical location and in database), lab instruments management as well as create research material e-shipping
  • Capable on teaching and training junior research staffs and biomedical students.

RESEARCH SPECIALIST

D Pulmonary, Allergy, and Critical Care
10.2015 - 11.2017

Projects: Discovery of LAM disease development and potential therapy on bench and clinical research

  • Adhering to adherence to IRB-approved human research protocol and executing primary human LAM cell isolation from patients’ lung tissue and LAM cell culture and banking
  • Designing and execute cell based assays to characterize human LAM cell phenotype as well as the mechanism on LAM cell development
  • Developing and performing assays in vitro and in vivo (with potential LAM mouse model) to discover the therapies for delaying LAM disease progress
  • Performing research data analysis/presentation in ATCC Annual Meeting/manuscript preparation and publication
  • Engaging in lab projects progress management, collaboration, human specimen shipping/handling as well as ordering/managing lab supplies
  • Playing the role as lab manager.

RESEARCH SPECIALIST C-D

University of Pennsylvania, Medicine, Hem/Onc.
08.2002 - 10.2015

Projects:

The role of platelet lipids plays in hemostasis/thrombosis as well as metastasis


Duties:

  • Generating/renewing animal research protocols for IACUC approval and supervising/executing lab knockout(ko) mice models generation, ko mice colonies maintaining, genotyping and phenotyping
  • Establishing human/mouse primary cell lines as well as characterizing primary cells
  • Providing and executing cell-based/animal based assays and bioassays (including lipids based assays)
  • Responsible on producing/analyzing/presenting research data in-group meeting/regional meeting/ASH annual meeting as well as writing manuscript for publication
  • Managing /executing collaborated projects and being capable training junior staffs and biomedical students.

Education

Bachelor of Medicine -

Changzhi Medical School

MS - Translational medicine

West China University of Medical Sciences

Master in Translational Research -

UPENN

Skills

  • Expertise in Cell Culture for both prokaryotic cell and eukaryotic cell
  • Cell Line Development for both tumor cell and CAR T/CAR Macrophage Cell Generation, Purification, Validation, Cryopreservation
  • Expertise on Lentivirus / Retrovirus Generation, Lentivirus Packaging, Titration and Transduction
  • Chimeric Antigen Receptor Development
  • Hands-on skills on Bone Marrow Isolation, Hematopoietic Stem Cell (HSC) Isolation, Differentiation, Expansion and Cryopreservation
  • Experienced in Flow Cytometry Techniques and Flow data Analysis with Flowjo
  • Expertise on PBMCs isolation, T Cell or Monocyte Isolation, expansions, Validation and Cryopreservation
  • Hand-on skills on In vitro, In Vivo and ex vivo experiments and experimental data Analysis
  • Proficient in Tumor Model Development,, Phenotypic analysis on Tumor Infiltrated Immune cell (TILs) by flow or ex vivo function assay
  • Mice Care Expertise and genetic modification, Genotyping Techniques Expertise
  • Accurate Specimen Collection Techniques, Tissue Analysis for functional or morphological studies
  • Quantitative Immunological Testing, Western Blot Analysis, Proficient in ELISA Techniques, Multiplex Assay, MSD Plex/immunoassay platform Immunostaining, Proficiency
  • Cell-Based Assay Development, Cell Viability Assessment, Cell Growth/Apoptosis Analysis
  • Proficient in Intercellular Interactions, Ligand-cell interactions
  • Cell Spreading, Inhibition, Activation, Aggregation or /and Secretion
  • Cell Morphology Assessment
  • Crispr Cas9 gene modification, DNA or /and RNA extraction, cDNA synthesis, RT-qPCR, DNA amplification, sequence verification
  • Plasmid DNA reconstruction, Cloning with PCR cloning and Subcloning, DNA purification, SiRNA transfection
  • Southern/ Northern blotting
  • Bacterial-Viral protein synthesis, Purification, Dialysis, Concentration
  • Protein-lipid interaction
  • Calcium flux assay, Annexin V measurement, Cell signal transduction assay
  • Lipids level measurement
  • Skilled on Microscope, Fluorescent microscope, Confocal microscope usa
  • Plate reader IncuCyte, NC-200
  • Flow Cytometry (BD LSRFortessa™, Attune NxT, LI-COR Odyssey, qPCR instruments, MSD/Luminex plat-reader, NC-200
  • Expertise on using Microsoft Office, Flowjo, Fiji imagej, SlideReviewer, Halo, LiveImage, IVIS Live Image, GraphPad
  • Proficiency usiing ENL (Benchling and Benchling in vivo module
  • Experienced in Writing & Reviewing experimental SOP for IND application

Certification

  • Certified on Charles River Laboratories mice handling, safety, as well as all animal related procedures, as well as Apollo for CRADL.
  • The Certification of Completion of The Test OF HIPAA Privacy Education for University of Pennsylvania SOM staff Assessment (issue #: 0000022170HPSPAAE4).
  • The Certification of Completion of Lab Research Management Training certified by The University of Pennsylvania.
  • The Certification of completion of CITI protection of human subjects research training-ORA.
  • The Certification of Hands-on Lab Animal handling issued by The Institutional Animal Care and Use Committee, ULAR of UPENN.
  • Certification of Completion of Regulations and the IACUC Modules 1-6 certified by The University of Pennsylvania.
  • Certification of Completion of Recombinant DNA Training certified by The University of Pennsylvania.
  • Certification of Completion of Knowledge Link Supervisor Tutorial certified by The University of Pennsylvania.
  • Certification of Completion of Bloodborne Pathogenes Annual Update-EHRS certified by The University of Pennsylvania.

Publications/presentations

  • Pre-clinical efficacy of a novel anti-GPC3 in vivo CAR-M for hepatocellular carcinoma, SITC 2024, 11/08/24
  • Lymphangioleiomyomatosis (LAM) Cell Survival Is Driven by IGF2-Induced STAT3 Activation, American Journal of Respiratory and Critical Care Medicine, 2017
  • TSC2-dependent STAT3-mediated upregulation of IGF2 induces autocrine STAT3 activation through JAK2 in LAM models, Department of Medicine 2017 research day, Perelman Medical School of University Pennsylvania, 05/09/17
  • PD-L1 as a Potential Target for Patients with Advanced or Refractory-to-Rapamycin LAM, Department of Medicine 2017 research day, Perelman Medical School of University Pennsylvania, 05/09/17

Selectedpublications

  • Pre-clinical efficacy of a novel anti-GPC3 in vivo CAR-M for hepatocellular carcinoma, J Immunother Cancer, 11/08/24
  • Chimeric antigen receptor macrophages (CAR-M) sensitize HER2+ solid tumors to PD1 blockade in pre-clinical models, Nature Communications, 2024
  • Addition of anti-TIM3 or anti-TIGIT Antibodies to anti-PD1 Blockade Augments Human T cell Adoptive Cell Transfer, Oncoimmunology, 01/01/21
  • Immune Checkpoint Ligand PD-L1 Is Upregulated in Pulmonary Lymphangioleiomyomatosis, Am J Respir Cell Mol Biol, 12/01/18
  • Rapamycin-independent IGF2 expression in Tsc2-null mouse embryo fibroblasts and human lymphangioleiomyomatosis cells, PLoS One, 05/14/18
  • Platelet PITPa is required for tumor metastasis formation, but is not essential for hemostasis, Nature Communications, 2017
  • Loss of ATE1-mediated arginylation leads to impaired platelet myosin phosphorylation, clot retraction, and in vivo thrombosis formation, Haematologica, 03/01/14
  • Platelets lacking PIP5K1g have normal integrin activation but impaired cytoskeletal-membrane integrity and adhesion, Blood, 04/01/13
  • Loss of pleckstrin defines a novel pathway for PKC-mediated exocytosis, Blood, 04/01/09
  • Requirements of SLP76 tyrosines in ITAM and integrin receptor signaling and in platelet function in vivo, Exp. Med, 08/01/08
  • Loss of PIP5Kβ demonstrates the PIP5K isoform-specific PIP2 synthesis is required for IP3 formation, PNAS, 09/01/08
  • Phospholipase Cbeta is critical for T cell chemotaxis, The Journal of Immunology, 10/01/07
  • PIP5K1γ is required for cardiovascular and neuronal development, PNAS, 07/01/07
  • The relative role of PLCbeta and PI3Kγ in platelet activation, Blood, 07/01/05
  • Anti-sickling effect of MX-1520, a prodrug of vanillin: an in vivo study using roents, Br J Haematol, 06/01/04

Languages

English
Native or Bilingual

Reference

Note: References available only upon request


1. Stefano Pierini, PhD, Principal Scientist, Discovery in vivo, Carisma Therapeutics, Inc._ He is my in vivo team leader and my direct research project supervisor when I worked in Carisma Therapeutics Inc. He knows my professional skills and knowledge as well as my capabilities on independently carrying on in vitro, in vivo, as well as ex vivo study, data collection/analysis/summarization/presentation skills as well as collaboratory skill and research projects contributions.

2. Kevin W. Tosh PhD., Principal Scientist at Interius BioTherapeutics. He, as a principal Scientist, previously worked in Discovery in vitro at Carisma Therapeutics, Inc. He knew me very well because I worked on one of the projects, that He led.

3. Edmund Moon, MD. Specialized as interventional pulmonologist, Assistant Professor, the medical director of cancer immunotherapy in GSK – he is my direct principal investigator during the years 2017- current and the best person to be contacted for you. Because he knows my knowledge and professional skills as well as my personal characters.

4. Rashid Gabbasov, PhD. Senior Scientist, Discovery in vivo team. He know me because we worked in the same team.

Timeline

SENIOR ASSOCIATE

SCIENTIST Carisma Therapeutic, Inc, Discovery
06.2022 - 12.2024

RESEARCH SPECIALIST

D MED, University of Pennsylvania, Pulmonary, Alle
11.2017 - 06.2022

RESEARCH SPECIALIST

D Pulmonary, Allergy, and Critical Care
10.2015 - 11.2017

RESEARCH SPECIALIST C-D

University of Pennsylvania, Medicine, Hem/Onc.
08.2002 - 10.2015

MS - Translational medicine

West China University of Medical Sciences

Master in Translational Research -

UPENN

Bachelor of Medicine -

Changzhi Medical School
Lauren Lian